SCWorx Corp. WORX
- Market cap
- $1.2M
- P/E
- 0.2×
Follow WORX
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 167,238.00 | 43,605.00 | 6,771.60 | 5,130.00 | 2,700.00 | 3,132.00 | 1,026.00 | 293.40 | 135.72 | 33.30 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 280,611.00 | 204,840.91 | 79,002.00 | 30,753.00 | 40,176.00 | 13,500.00 | 3,996.00 | 2,592.00 | 799.20 | 367.20 |
High Price
|
|||
| 36 | 34 | 4 | 4 | 9 | 10 | 9 | 7 | 7 | 9 |
Employees
|
|||
| 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
Revenue/Emp
|
|||
| 1 | 0 | 3 | 6 | 5 | 5 | 4 | 4 | 3 | 3 |
Revenue
|
|||
| 35.00% | 100.00% | 14.83% | 21.02% | 32.57% | 39.94% | 35.01% | 33.35% | 24.95% | 31.96% |
Gross Margin
|
|||
| (5) | (3) | 0 | (11) | (7) | (4) | (2) | (4) | (1) | (4) |
EBT
|
|||
| (831.08%) | (1,436.84%) | (11.12%) | (203.90%) | (142.00%) | (82.34%) | (45.75%) | (104.63%) | (38.01%) | (154.44%) |
EBT Margin
|
|||
| (4) | (12) | 0 | (11) | (7) | (4) | (2) | (4) | (1) | (4) |
Net Income
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | — | — | 0 | 3 |
Depreciation
|
|||
| 5,914.00 | 1,103.50 | 2,012.88 | 2,412.22 | 1,533.26 | 1,187.82 | 917.77 | 667.53 | 369.09 | 71.23 |
Revenue/Sh
|
|||
| (38,649.65) | (57,448.54) | (229.45) | (4,884.07) | (2,222.87) | (984.02) | (404.76) | (694.73) | (140.39) | (109.79) |
Earnings/Sh
|
|||
| (20,181.00) | (29,141.50) | (141.82) | (2,039.70) | (282.09) | (274.33) | (122.73) | (141.44) | (133.86) | (38.21) |
Cash Flow/Sh
|
|||
| (1,116.00) | 0.00 | 0.00 | (48.57) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.76) |
Capex/Sh
|
|||
| (21,297.00) | (29,141.50) | (141.82) | (2,088.26) | (282.09) | (274.33) | (122.73) | (141.44) | (133.86) | (38.97) |
Free CF/Sh
|
|||
| 137,118.00 | 40,672.50 | (136.41) | 3,011.13 | 1,686.47 | 1,642.33 | 1,540.11 | 676.04 | 554.27 | 177.04 |
Book Value/Sh
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| 0.00 | 58.11 | 4.13 | 3.21 | 2.38 | 2.93 | 1.14 | 0.49 | 0.82 | 0.47 |
PS Ratio
|
|||
| 1.40 | 1.58 | 0.00 | 2.57 | 2.16 | 2.12 | 0.68 | 0.49 | 0.55 | 0.19 |
PB Ratio
|
|||
| 0.00 | 58.45 | 4.17 | 3.13 | 2.37 | 3.02 | 1.12 | 0.50 | 0.80 | (0.10) |
EV/Sales
|
|||
| (7.21) | (2.21) | (59.12) | (3.61) | (11.82) | (12.10) | (7.27) | (2.13) | (2.05) | 0.18 |
EV/FCF
|
|||
| (2) | (6) | 0 | (5) | (1) | (1) | (1) | (1) | (1) | (2) |
Op' Cash Flow
|
|||
| 0 | — | — | 0 | — | — | — | — | — | 0 |
Capex
|
|||
| (2) | (6) | 0 | (5) | (1) | (1) | (1) | (1) | (1) | (2) |
FCF
|
|||
| 5 | (1) | 0 | (2) | (2) | (2) | (1) | (2) | (1) | 1 |
Working Cap'
|
|||
| — | 0 | 2 | — | 0 | 0 | 0 | 0 | 0 | — |
Total Debt
|
|||
| (5) | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | (2) |
Net Debt
|
|||
| 14 | 8 | 0 | 7 | 6 | 6 | 7 | 4 | 4 | 7 |
Sh' Equity
|
|||
| (59.33%) | (100.87%) | (5.95%) | (173.71%) | (71.80%) | (38.63%) | (20.11%) | (51.29%) | (18.00%) | (62.41%) |
ROA
|
|||
| (33.98%) | (24.49%) | (7.77%) | (115.51%) | (66.85%) | (35.23%) | (19.88%) | (23.54%) | (17.88%) | (10.88%) |
ROIC
|
|||
| (62.40%) | (109.66%) | (9.63%) | (338.03%) | (116.95%) | (62.85%) | (28.03%) | (74.90%) | (27.24%) | (76.35%) |
ROE
|
|||
SCWorx Corp. peers in Health Information Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| MSPR MSP Recovery, Inc. | $1.5M | 0.0× | Compare |
| MNDR Mobile-health Network Solutions | $1.7M | — | Compare |
| LGMK LogicMark, Inc. | $1.7M | 0.0× | Compare |
| ICCT iCoreConnect Inc. | $800.0K | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| VSEED VSee Health, Inc. | $2.8M | 0.0× | Compare |
| HLTHQ Cue Health Inc. | $6.9M | 0.0× | Compare |
| ACON Aclarion, Inc. | $7.6M | 0.0× | Compare |
| ZCMD Zhongchao Inc. | $8.8M | 0.0× | Compare |
SCWorx Corp. (WORX) key facts
- SCWorx Corp. (WORX) is a Health Information Services company in the Healthcare sector.
- SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024.
- As of September 24, 2026, WORX traded at $3.50, a market capitalization of $1.2 million.
- Return on equity was −76.4% and debt-to-equity 0.00.
SCWorx Corp. (WORX) Latest News
17 Sep
SCWorx Corp. (WORX) announces equity financing with institutional investors. Equity financing supplies SCWorx with fresh capital but risks share dilution and shifts market sentiment.
6 Aug
SCWorx secures two-year agreement with one of Massachusetts’ largest integrated delivery networks. New contract adds revenue from major regional healthcare provider without altering overall company trajectory.
29 Jul
SCWorx received a partial compliance letter from the Nasdaq Hearings Panel for continued listing on the Nasdaq Capital Market. Partial Nasdaq compliance advances listing status and supports market access without eliminating all risks.
8 Jul
SCWorx Corp. deploys an AI-assisted data management model for healthcare supply chain data attributes. AI deployment targets core healthcare supply chain operations and may moderately improve efficiency and positioning.
23 Jun
SCWorx Corp. gains Nasdaq Hearings Panel approval to maintain its Nasdaq listing, contingent upon satisfying specified compliance conditions. Continued Nasdaq listing prevents potential sharp decline in stock liquidity and investor access.
4 Mar
SCWorx announces new SaaS and data management customer—a prominent Southeastern healthcare provider—providing support for its Workday platform. Landing a prominent healthcare provider as a SaaS customer validates SCWorx's pivot to recurring revenue and enhances growth prospects.
12 Feb
SCWorx Corp. (WORX) has been identified as one of the most active stocks in the market, indicating heightened trading activity and interest among investors. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance. Increased trading activity suggests a moderately noticeable influence on market sentiment and investor interest.
23 Jan
SCWorx Corp. (WORX) has been identified as one of the most active stocks in the market, reflecting heightened trading activity and investor interest. The company's recent developments and market performance have contributed to its visibility among investors, indicating potential shifts in market dynamics. Increased trading activity suggests a moderate influence on market sentiment and potential financial performance.
17 Dec
SCWorx Corp. has secured a new customer in the academic hospital sector, enhancing its portfolio and expanding its market reach. This partnership is expected to bolster the company's presence in the healthcare industry, potentially leading to increased revenue and growth opportunities. The new customer acquisition is likely to moderately influence SCWorx's financial performance and market positioning.
15 Dec
SCWorx Corp. has announced a new partnership aimed at expanding its healthcare data management network. This collaboration is expected to enhance the company's capabilities in managing healthcare data, potentially improving service delivery and operational efficiency. The partnership aligns with SCWorx's strategy to strengthen its position in the healthcare sector and respond to growing demand for data management solutions. The partnership is a significant strategic move that could enhance SCWorx's competitive positioning in the healthcare data management market.
14 Oct
SCWorx Corp. has been granted a 180-day extension by Nasdaq to comply with the minimum bid price requirement. The extension allows the company until May 2024 to achieve a closing bid price of at least $1 per share for 10 consecutive trading days. Failure to meet this requirement may result in delisting from the exchange. SCWorx is actively working to regain compliance and is exploring various options to enhance its market position. The extension provides SCWorx with critical time to improve its stock price, which could influence investor sentiment and market performance.
6 Oct
SCWorx Corp. has renewed its agreement with an existing healthcare partner for an additional three years, resulting in a 113% increase in contract value. This renewal signifies a strengthened relationship and potential for increased revenue for the company. The significant increase in contract value and extended partnership is likely to enhance SCWorx's financial performance and market position.
3 Sep
SCWorx Corp. has appointed a new Chief Technology Officer to enhance its healthcare data solutions. This strategic move aims to accelerate innovation within the company, positioning it to better serve the healthcare sector and improve its technological capabilities. The appointment of a new CTO is a significant strategic move that could enhance product innovation and competitive positioning in the healthcare data solutions market.
26 Aug
SCWorx Corp. has announced a new collaboration aimed at expanding its healthcare data management network. This initiative is expected to enhance the company's capabilities in managing healthcare data, potentially improving service delivery and operational efficiency. The collaboration aligns with SCWorx's strategic goals to strengthen its position in the healthcare sector and leverage data management solutions. The collaboration is a significant strategic move that could enhance SCWorx's competitive positioning in the healthcare data management market.
SCWorx Corp. (WORX) has been identified as one of the most active stocks in the market, indicating heightened trading activity and interest among investors. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance. Increased trading activity suggests a moderately noticeable influence on market sentiment and investor interest.
13 Aug
Florida Hospital has selected SCWorx Corp. for data management services as part of its Workday implementation. This partnership aims to enhance the hospital's operational efficiency and data handling capabilities, leveraging SCWorx's expertise in data management solutions. The partnership with Florida Hospital represents a significant strategic move that could enhance SCWorx's market position and financial performance.
10 Jul
Former CEO of SCWorx Corp convicted of securities fraud for falsely claiming to be a major supplier of COVID-19 rapid tests, leading to a 400% increase in share price. The conviction of the former CEO for securities fraud and false claims about COVID-19 tests could have a significant impact on SCWorx Corp's future and market performance.
Former CEO of SCWorx misled investors about acquiring Covid-19 test kits. Misleading investors about test kits could significantly impact SCWorx Corp.'s future and market performance.
21 May
SCWorx Corp. received notice from NASDAQ for not filing required periodic reports, engaged new auditor to regain compliance. The delayed filings and engagement of a new auditor may moderately influence SCWorx Corp.'s financial performance and compliance status.
23 Oct
SCWorx Corp. signs letter of intent to acquire American Environmental Partners, Inc. The acquisition of American Environmental is expected to substantially increase SCWorx's revenue and improve cashflow.
10 Oct
SCWorx Corp. shareholders approve reverse stock split at annual meeting. The reverse stock split decision is expected to have a moderately noticeable influence on the company's future performance and market positioning.